Survival Benefit for Pediatric Patients With Recurrent Ependymoma Treated With Reirradiation
- 1 August 2012
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 83 (5), 1541-1548
- https://doi.org/10.1016/j.ijrobp.2011.10.039
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Stereotactic radiosurgery for pediatric recurrent intracranial ependymomasJournal of Neurosurgery: Pediatrics, 2010
- Immune Gene and Cell Enrichment Is Associated with a Good Prognosis in EpendymomaThe Journal of Immunology, 2009
- Relapsed intracranial ependymoma in children in the UK: Patterns of relapse, survival and therapeutic outcomeEuropean Journal of Cancer, 2009
- Maximally safe resection followed by hypofractionated re‐irradiation for locally recurrent ependymoma in childrenPediatric Blood & Cancer, 2009
- Telomere maintenance and dysfunction predict recurrence in paediatric ependymomaBritish Journal of Cancer, 2008
- The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factorsLaboratory Investigation, 2008
- Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective studyThe Lancet Oncology, 2007
- Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpointsNature, 2006
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- Childhood EpendymomaPediatric Drugs, 2003